Active 0 6 0 6 O
heart 7 12 7 12 B-chronic_disease
disease 13 20 13 20 I-chronic_disease
including 21 30 21 30 O
myocardial 31 41 31 41 B-chronic_disease
infarction 42 52 42 52 I-chronic_disease
within 53 59 53 59 O
previous 60 68 60 68 B-upper_bound
3 69 70 69 70 I-upper_bound
months 71 77 71 77 I-upper_bound

Age 0 3 78 81 B-age
> 4 5 82 83 O
/=18 5 9 83 87 O
years 10 15 88 93 I-lower_bound

Eastern 0 7 94 101 B-clinical_variable
Cooperative 8 19 102 113 I-clinical_variable
Oncology 20 28 114 122 I-clinical_variable
Group 29 34 123 128 I-clinical_variable
( 35 36 129 130 I-clinical_variable
ECOG 36 40 130 134 I-clinical_variable
) 40 41 134 135 I-clinical_variable
performance 42 53 136 147 I-clinical_variable
status 54 60 148 154 I-clinical_variable
of 61 63 155 157 O
0 64 65 158 159 B-lower_bound
- 65 66 159 160 O
2 66 67 160 161 B-upper_bound

For 0 3 162 165 O
Arm 4 7 166 169 O
E 8 9 170 171 O
, 9 10 171 172 O
in 11 13 173 175 O
addition 14 22 176 184 O
to 23 25 185 187 O
patients 26 34 188 196 O
with 35 39 197 201 O
relapsed 40 48 202 210 B-cancer
or 49 51 211 213 I-cancer
refractory 52 62 214 224 I-cancer
acute 63 68 225 230 I-cancer
leukemias 69 78 231 240 I-cancer
or 79 81 241 243 O
high 82 86 244 248 B-cancer
- 86 87 248 249 I-cancer
risk 87 91 249 253 I-cancer
MDS 92 95 254 257 I-cancer
, 95 96 257 258 O
patients 97 105 259 267 O
with 106 110 268 272 O
untreated 111 120 273 282 O
high 121 125 283 287 O
- 125 126 287 288 O
risk 126 130 288 292 O
MDS 131 134 293 296 O
or 135 137 297 299 O
acute 138 143 300 305 O
leukemias 144 153 306 315 O

For 0 3 316 319 O
Arms 4 8 320 324 O
A 9 10 325 326 O
, 10 11 326 327 O
B 12 13 328 329 O
, 13 14 329 330 O
C 15 16 331 332 O
, 16 17 332 333 O
D 18 19 334 335 O
patients 20 28 336 344 O
must 29 33 345 349 O
have 34 38 350 354 O
relapsed 39 47 355 363 O
or 48 50 364 366 O
refractory 51 61 367 377 O
acute 62 67 378 383 B-cancer
leukemias 68 77 384 393 I-cancer
or 78 80 394 396 O
high 81 85 397 401 B-cancer
- 85 86 401 402 I-cancer
risk 86 90 402 406 I-cancer
MDS 91 94 407 410 I-cancer
for 95 98 411 414 O
which 99 104 415 420 O
no 105 107 421 423 O
standard 108 116 424 432 O
therapies 117 126 433 442 B-treatment
are 127 130 443 446 O
anticipated 131 142 447 458 O
to 143 145 459 461 O
result 146 152 462 468 O
in 153 155 469 471 O
a 156 157 472 473 O
durable 158 165 474 481 O
remission 166 175 482 491 O

Known 0 5 492 497 O
history 6 13 498 505 O
of 14 16 506 508 O
seropositive 17 29 509 521 O
for 30 33 522 525 O
human 34 39 526 531 B-chronic_disease
immunodeficiency 40 56 532 548 I-chronic_disease
virus 57 62 549 554 I-chronic_disease
( 63 64 555 556 I-chronic_disease
HIV 64 67 556 559 I-chronic_disease
) 67 68 559 560 I-chronic_disease
antibodies 69 79 561 571 O
( 80 81 572 573 O
HIV1 81 85 573 577 B-chronic_disease
and 86 89 578 581 O
HIV2 90 94 582 586 B-chronic_disease
) 94 95 586 587 O
, 95 96 587 588 O
Hepatitis 97 106 589 598 B-chronic_disease
C 107 108 599 600 I-chronic_disease
antibody 109 117 601 609 O
( 118 119 610 611 O
Hep 119 122 611 614 B-chronic_disease
C 123 124 615 616 I-chronic_disease
Ab 125 127 617 619 O
) 127 128 619 620 O
or 129 131 621 623 O
a 132 133 624 625 O
Hepatitis 134 143 626 635 B-chronic_disease
B 144 145 636 637 I-chronic_disease
carrier 146 153 638 645 O
( 154 155 646 647 O
positive 155 163 647 655 O
for 164 167 656 659 O
Hepatitis 168 177 660 669 O
B 178 179 670 671 O
surface 180 187 672 679 O
antigen 188 195 680 687 O
[ 196 197 688 689 O
HBsAg 197 202 689 694 O
] 202 203 694 695 O
) 203 204 695 696 O

No 0 2 697 699 O
active 3 9 700 706 O
graft 10 15 707 712 B-chronic_disease
- 15 16 712 713 I-chronic_disease
versus 16 22 713 719 I-chronic_disease
- 22 23 719 720 I-chronic_disease
host 23 27 720 724 I-chronic_disease
disease 28 35 725 732 I-chronic_disease
( 36 37 733 734 O
GVHD 37 41 734 738 B-clinical_variable
> 42 43 739 740 O
grade 44 49 741 746 B-lower_bound
1 50 51 747 748 I-lower_bound
) 51 52 748 749 O

No 0 2 750 752 O
treatment 3 12 753 762 B-treatment
with 13 17 763 767 O
high 18 22 768 772 O
dose 23 27 773 777 O
steroids 28 36 778 786 B-treatment
for 37 40 787 790 O
GVHD 41 45 791 795 B-chronic_disease
( 46 47 796 797 O
up 47 49 797 799 O
to 50 52 800 802 O
> 53 54 803 804 O
/= 54 56 804 806 O
20 57 59 807 809 B-lower_bound
mg 60 62 810 812 I-lower_bound
Prednisolone 63 75 813 825 B-treatment
or 76 78 826 828 O
equivalent 79 89 829 839 O
per 90 93 840 843 O
day 94 97 844 847 O
) 97 98 847 848 O

No 0 2 849 851 O
treatment 3 12 852 861 B-treatment
with 13 17 862 866 O
immunosuppressive 18 35 867 884 B-treatment
drugs 36 41 885 890 I-treatment
with 42 46 891 895 O
the 47 50 896 899 O
exception 51 60 900 909 O
of 61 63 910 912 O
low 64 67 913 916 O
dose 68 72 917 921 O
cyclosporine 73 85 922 934 B-treatment
and 86 89 935 938 O
tacrolimus 90 100 939 949 B-treatment

Patients 0 8 950 958 O
must 9 13 959 963 O
have 14 18 964 968 O
the 19 22 969 972 O
following 23 32 973 982 O
clinical 33 41 983 991 O
laboratory 42 52 992 1002 O
values 53 59 1003 1009 O
unless 60 66 1010 1016 O
considered 67 77 1017 1027 O
due 78 81 1028 1031 O
to 82 84 1032 1034 O
leukemic 85 93 1035 1043 O
organ 94 99 1044 1049 O
involvement 100 111 1050 1061 O
: 111 112 1061 1062 O
( 113 114 1063 1064 O
1 114 115 1064 1065 O
) 115 116 1065 1066 O
Serum 117 122 1067 1072 B-clinical_variable
creatinine 123 133 1073 1083 I-clinical_variable
< 134 135 1084 1085 O
2.0 136 139 1086 1089 B-upper_bound
mg 140 142 1090 1092 I-upper_bound
/ 142 143 1092 1093 I-upper_bound
dl 143 145 1093 1095 I-upper_bound
; 145 146 1095 1096 O
( 147 148 1097 1098 O
2 148 149 1098 1099 O
) 149 150 1099 1100 O
Total 151 156 1101 1106 B-clinical_variable
bilirubin 157 166 1107 1116 I-clinical_variable
< 167 168 1117 1118 O
/= 168 170 1118 1120 O
1.5 171 174 1121 1124 B-upper_bound
x 175 176 1125 1126 I-upper_bound
the 177 180 1127 1130 I-upper_bound
upper 181 186 1131 1136 I-upper_bound
limit 187 192 1137 1142 I-upper_bound
of 193 195 1143 1145 I-upper_bound
normal 196 202 1146 1152 I-upper_bound
( 203 204 1153 1154 I-upper_bound
ULN 204 207 1154 1157 I-upper_bound
) 207 208 1157 1158 I-upper_bound
unless 209 215 1159 1165 O
considered 216 226 1166 1176 O
due 227 230 1177 1180 O
to 231 233 1181 1183 O
Gilbert 234 241 1184 1191 B-chronic_disease
's 241 243 1191 1193 I-chronic_disease
syndrome 244 252 1194 1202 I-chronic_disease
; 252 253 1202 1203 O
( 254 255 1204 1205 O
3 255 256 1205 1206 O
) 256 257 1206 1207 O
Alanine 258 265 1208 1215 B-clinical_variable
aminotransferase 266 282 1216 1232 I-clinical_variable
( 283 284 1233 1234 I-clinical_variable
ALT 284 287 1234 1237 I-clinical_variable
) 287 288 1237 1238 I-clinical_variable
, 288 289 1238 1239 I-clinical_variable
or 290 292 1240 1242 I-clinical_variable
aspartate 293 302 1243 1252 I-clinical_variable
aminotransferase 303 319 1253 1269 I-clinical_variable
( 320 321 1270 1271 I-clinical_variable
AST 321 324 1271 1274 I-clinical_variable
) 324 325 1274 1275 I-clinical_variable
< 326 327 1276 1277 O
/= 327 329 1277 1279 O
3 330 331 1280 1281 B-upper_bound
x 332 333 1282 1283 I-upper_bound
the 334 337 1284 1287 I-upper_bound
ULN 338 341 1288 1291 I-upper_bound
unless 342 348 1292 1298 O
considered 349 359 1299 1309 O
due 360 363 1310 1313 O
to 364 366 1314 1316 O
organ 367 372 1317 1322 O
leukemic 373 381 1323 1331 O
involvement 382 393 1332 1343 O

Patients 0 8 1344 1352 O
receiving 9 18 1353 1362 O
any 19 22 1363 1366 O
other 23 28 1367 1372 O
standard 29 37 1373 1381 O
or 38 40 1382 1384 O
investigational 41 56 1385 1400 B-treatment
treatment 57 66 1401 1410 I-treatment
for 67 70 1411 1414 O
their 71 76 1415 1420 O
hematologic 77 88 1421 1432 B-cancer
malignancy 89 99 1433 1443 I-cancer
within 100 106 1444 1450 O
past 107 111 1451 1455 B-upper_bound
2 112 113 1456 1457 I-upper_bound
weeks 114 119 1458 1463 I-upper_bound
for 120 123 1464 1467 O
cytotoxic 124 133 1468 1477 B-treatment
agents 134 140 1478 1484 I-treatment
or 141 143 1485 1487 O
at 144 146 1488 1490 O
least 147 152 1491 1496 O
5 153 154 1497 1498 B-lower_bound
half 155 159 1499 1503 I-lower_bound
- 159 160 1503 1504 I-lower_bound
lives 160 165 1504 1509 I-lower_bound
for 166 169 1510 1513 O
noncytotoxic 170 182 1514 1526 B-treatment
agents 183 189 1527 1533 I-treatment

Patients 0 8 1534 1542 O
with 9 13 1543 1547 O
known 14 19 1548 1553 O
central 20 27 1554 1561 B-chronic_disease
nervous 28 35 1562 1569 I-chronic_disease
system 36 42 1570 1576 I-chronic_disease
( 43 44 1577 1578 I-chronic_disease
CNS 44 47 1578 1581 I-chronic_disease
) 47 48 1581 1582 I-chronic_disease
disease 49 56 1583 1590 I-chronic_disease
are 57 60 1591 1594 O
allowed 61 68 1595 1602 O
if 69 71 1603 1605 O
there 72 77 1606 1611 O
is 78 80 1612 1614 O
no 81 83 1615 1617 O
evidence 84 92 1618 1626 O
of 93 95 1627 1629 O
active 96 102 1630 1636 O
CNS 103 106 1637 1640 B-chronic_disease
disease 107 114 1641 1648 I-chronic_disease
as 115 117 1649 1651 O
documented 118 128 1652 1662 O
by 129 131 1663 1665 O
negative 132 140 1666 1674 O
imaging 141 148 1675 1682 O
or 149 151 1683 1685 O
spinal 152 158 1686 1692 O
fluid 159 164 1693 1698 O
analysis 165 173 1699 1707 O
carried 174 181 1708 1715 O
out 182 185 1716 1719 O
at 186 188 1720 1722 O
least 189 194 1723 1728 O
2 195 196 1729 1730 B-lower_bound
weeks 197 202 1731 1736 I-lower_bound
prior 203 208 1737 1742 I-lower_bound
to 209 211 1743 1745 O
study 212 217 1746 1751 B-treatment
drug 218 222 1752 1756 I-treatment
administration 223 237 1757 1771 O

Persistent 0 10 1772 1782 O
clinically 11 21 1783 1793 O
significant 22 33 1794 1805 O
toxicities 34 44 1806 1816 O
from 45 49 1817 1821 O
prior 50 55 1822 1827 B-treatment
therapy 56 63 1828 1835 I-treatment
must 64 68 1836 1840 O
not 69 72 1841 1844 O
be 73 75 1845 1847 O
greater 76 83 1848 1855 O
than 84 88 1856 1860 O
grade 89 94 1861 1866 B-lower_bound
1 95 96 1867 1868 I-lower_bound

Pregnant 0 8 1869 1877 B-pregnancy
and 9 12 1878 1881 O
nursing 13 20 1882 1889 O
patients 21 29 1890 1898 O
are 30 33 1899 1902 O
excluded 34 42 1903 1911 O
because 43 50 1912 1919 O
the 51 54 1920 1923 O
effects 55 62 1924 1931 O
of 63 65 1932 1934 O
ONC201on 66 74 1935 1943 B-treatment
a 75 76 1944 1945 O
fetus 77 82 1946 1951 O
or 83 85 1952 1954 O
nursing 86 93 1955 1962 O
child 94 99 1963 1968 O
are 100 103 1969 1972 O
unknown 104 111 1973 1980 O

Relapse 0 7 1981 1988 B-clinical_variable
> 8 9 1989 1990 O
6 10 11 1991 1992 B-lower_bound
months 12 18 1993 1999 I-lower_bound
since 19 24 2000 2005 O
autologous 25 35 2006 2016 B-treatment
or 36 38 2017 2019 O
allogeneic 39 49 2020 2030 B-treatment
stem 50 54 2031 2035 I-treatment
cell 55 59 2036 2040 I-treatment
transplantation 60 75 2041 2056 I-treatment

Sexually 0 8 2057 2065 O
active 9 15 2066 2072 O
men 16 19 2073 2076 B-gender
must 20 24 2077 2081 O
also 25 29 2082 2086 O
use 30 33 2087 2090 B-contraception_consent
acceptable 34 44 2091 2101 I-contraception_consent
contraceptive 45 58 2102 2115 I-contraception_consent
methods 59 66 2116 2123 O
for 67 70 2124 2127 O
the 71 74 2128 2131 O
duration 75 83 2132 2140 O
of 84 86 2141 2143 O
time 87 91 2144 2148 O
on 92 94 2149 2151 O
study 95 100 2152 2157 O
and 101 104 2158 2161 O
for 105 108 2162 2165 O
at 109 111 2166 2168 O
least 112 117 2169 2174 O
16 118 120 2175 2177 B-lower_bound
weeks 121 126 2178 2183 I-lower_bound
after 127 132 2184 2189 I-lower_bound
the 133 136 2190 2193 O
last 137 141 2194 2198 O
dose 142 146 2199 2203 O
of 147 149 2204 2206 O
study 150 155 2207 2212 B-treatment
drug 156 160 2213 2217 I-treatment

Subject 0 7 2218 2225 O
has 8 11 2226 2229 O
been 12 16 2230 2234 O
diagnosed 17 26 2235 2244 O
or 27 29 2245 2247 O
treated 30 37 2248 2255 O
for 38 41 2256 2259 O
another 42 49 2260 2267 O
malignancy 50 60 2268 2278 B-cancer
within 61 67 2279 2285 O
3 68 69 2286 2287 B-upper_bound
years 70 75 2288 2293 I-upper_bound
of 76 78 2294 2296 O
enrolment 79 88 2297 2306 O

The 0 3 2307 2310 O
interval 4 12 2311 2319 O
from 13 17 2320 2324 O
prior 18 23 2325 2330 B-treatment
treatment 24 33 2331 2340 I-treatment
to 34 36 2341 2343 O
time 37 41 2344 2348 O
of 42 44 2349 2351 O
study 45 50 2352 2357 O
drug 51 55 2358 2362 O
administration 56 70 2363 2377 O
should 71 77 2378 2384 O
be 78 80 2385 2387 O
at 81 83 2388 2390 O
least 84 89 2391 2396 O
2 90 91 2397 2398 B-lower_bound
weeks 92 97 2399 2404 I-lower_bound
for 98 101 2405 2408 O
cytotoxic 102 111 2409 2418 B-treatment
agents 112 118 2419 2425 I-treatment
or 119 121 2426 2428 O
at 122 124 2429 2431 O
least 125 130 2432 2437 O
5 131 132 2438 2439 B-lower_bound
half 133 137 2440 2444 I-lower_bound
- 137 138 2444 2445 I-lower_bound
lives 138 143 2445 2450 I-lower_bound
for 144 147 2451 2454 O
noncytotoxic 148 160 2455 2467 B-treatment
agents 161 167 2468 2474 I-treatment

Uncontrolled 0 12 2475 2487 O
intercurrent 13 25 2488 2500 B-chronic_disease
illness 26 33 2501 2508 I-chronic_disease
including 34 43 2509 2518 O
, 43 44 2518 2519 O
but 45 48 2520 2523 O
not 49 52 2524 2527 O
limited 53 60 2528 2535 O
to 61 63 2536 2538 O
uncontrolled 64 76 2539 2551 B-chronic_disease
infection 77 86 2552 2561 I-chronic_disease
, 86 87 2561 2562 O
symptomatic 88 99 2563 2574 O
congestive 100 110 2575 2585 B-chronic_disease
heart 111 116 2586 2591 I-chronic_disease
failure 117 124 2592 2599 I-chronic_disease
( 125 126 2600 2601 O
New 126 129 2601 2604 B-clinical_variable
York 130 134 2605 2609 I-clinical_variable
Heart 135 140 2610 2615 I-clinical_variable
Association 141 152 2616 2627 I-clinical_variable
class 153 158 2628 2633 B-lower_bound
III 159 162 2634 2637 I-lower_bound
and 163 166 2638 2641 O
IV 167 169 2642 2644 B-upper_bound
) 169 170 2644 2645 O
, 170 171 2645 2646 O
uncontrolled 172 184 2647 2659 O
cardiac 185 192 2660 2667 B-chronic_disease
arrhythmia 193 203 2668 2678 I-chronic_disease
, 203 204 2678 2679 O
or 205 207 2680 2682 O
psychiatric 208 219 2683 2694 B-chronic_disease
illness 220 227 2695 2702 I-chronic_disease
/ 227 228 2702 2703 O
social 228 234 2703 2709 B-chronic_disease
situations 235 245 2710 2720 I-chronic_disease
that 246 250 2721 2725 O
would 251 256 2726 2731 O
limit 257 262 2732 2737 O
compliance 263 273 2738 2748 O
with 274 278 2749 2753 O
study 279 284 2754 2759 O
requirements 285 297 2760 2772 O

Women 0 5 2773 2778 B-gender
of 6 8 2779 2781 O
child 9 14 2782 2787 O
- 14 15 2787 2788 O
bearing 15 22 2788 2795 O
potential 23 32 2796 2805 O
( 33 34 2806 2807 O
i.e. 34 38 2807 2811 O
, 38 39 2811 2812 O
women 40 45 2813 2818 B-gender
who 46 49 2819 2822 O
are 50 53 2823 2826 O
pre 54 57 2827 2830 O
- 57 58 2830 2831 O
menopausal 58 68 2831 2841 O
or 69 71 2842 2844 O
not 72 75 2845 2848 O
surgically 76 86 2849 2859 O
sterile 87 94 2860 2867 O
) 94 95 2867 2868 O
must 96 100 2869 2873 O
use 101 104 2874 2877 B-contraception_consent
acceptable 105 115 2878 2888 I-contraception_consent
contraceptive 116 129 2889 2902 I-contraception_consent
methods 130 137 2903 2910 I-contraception_consent
( 138 139 2911 2912 O
abstinence 139 149 2912 2922 B-contraception_consent
, 149 150 2922 2923 O
intrauterine 151 163 2924 2936 B-contraception_consent
device 164 170 2937 2943 I-contraception_consent
[ 171 172 2944 2945 I-contraception_consent
IUD 172 175 2945 2948 I-contraception_consent
] 175 176 2948 2949 I-contraception_consent
, 176 177 2949 2950 O
oral 178 182 2951 2955 B-contraception_consent
contraceptive 183 196 2956 2969 I-contraception_consent
or 197 199 2970 2972 O
double 200 206 2973 2979 B-contraception_consent
barrier 207 214 2980 2987 I-contraception_consent
device 215 221 2988 2994 I-contraception_consent
, 221 222 2994 2995 O
such 223 227 2996 3000 O
as 228 230 3001 3003 O
a 231 232 3004 3005 O
condom 233 239 3006 3012 B-contraception_consent
, 239 240 3012 3013 O
diaphragm 241 250 3014 3023 B-contraception_consent
, 250 251 3023 3024 O
or 252 254 3025 3027 O
cervical 255 263 3028 3036 B-contraception_consent
/ 263 264 3036 3037 I-contraception_consent
vault 264 269 3037 3042 I-contraception_consent
cap 270 273 3043 3046 I-contraception_consent
) 273 274 3046 3047 O
, 274 275 3047 3048 O
for 276 279 3049 3052 O
16 280 282 3053 3055 B-upper_bound
weeks 283 288 3056 3061 I-upper_bound
after 289 294 3062 3067 I-upper_bound
the 295 298 3068 3071 O
last 299 303 3072 3076 O
dose 304 308 3077 3081 O
of 309 311 3082 3084 O
study 312 317 3085 3090 B-treatment
drug 318 322 3091 3095 I-treatment

arrhythmias 0 11 3096 3107 B-chronic_disease
not 12 15 3108 3111 O
controlled 16 26 3112 3122 O
by 27 29 3123 3125 O
medication 30 40 3126 3136 B-treatment

must 0 4 3137 3141 O
have 5 9 3142 3146 O
a 10 11 3147 3148 O
negative 12 20 3149 3157 B-pregnancy
serum 21 26 3158 3163 I-pregnancy
or 27 29 3164 3166 I-pregnancy
urine 30 35 3167 3172 I-pregnancy
pregnancy 36 45 3173 3182 I-pregnancy
test 46 50 3183 3187 O
within 51 57 3188 3194 O
1 58 59 3195 3196 B-upper_bound
week 60 64 3197 3201 I-upper_bound
prior 65 70 3202 3207 I-upper_bound
to 71 73 3208 3210 O
beginning 74 83 3211 3220 O
treatment 84 93 3221 3230 B-treatment
on 94 96 3231 3233 O
this 97 101 3234 3238 O
trial 102 107 3239 3244 O

symptomatic 0 11 3245 3256 O
coronary 12 20 3257 3265 B-chronic_disease
artery 21 27 3266 3272 I-chronic_disease
disease 28 35 3273 3280 I-chronic_disease

uncontrolled 0 12 3281 3293 O
congestive 13 23 3294 3304 B-chronic_disease
heart 24 29 3305 3310 I-chronic_disease
failure 30 37 3311 3318 I-chronic_disease
( 38 39 3319 3320 O
New 39 42 3320 3323 B-clinical_variable
York 43 47 3324 3328 I-clinical_variable
Heart 48 53 3329 3334 I-clinical_variable
Association 54 65 3335 3346 I-clinical_variable
class 66 71 3347 3352 B-lower_bound
III 72 75 3353 3356 I-lower_bound
and 76 79 3357 3360 O
IV 80 82 3361 3363 B-upper_bound
) 82 83 3363 3364 O

